Get started
Author

Hisataka Shoji

Observed names: H Shoji, H. Shoji, HISATAKA SHOJI, Hisataka SHOJI
Observed institutions: Cleveland Clinic, University of Louisville, Shiga University of Medical Science, Toray Industries, Inc. (Japan), Koga Hospital, Koto Hospital, Shin Koga Hospital, Toray Medical Co., Ltd. (Japan)
ORCID: 0000-0002-1766-6998
Observed ORCID: 0000-0002-1766-6998
OpenAlex ID: A5101672662
Extracorporeal Endotoxin Removal For The Treatment of Sepsis:Endotoxin Adsorption Cartridge (Toraymyxin)
2003 · Hisataka Shoji · Therapeutic Apheresis and Dialysis · 375
Extracorporeal Endotoxin Removal by Polymyxin B Immobilized Fiber Cartridge: Designing and Antiendotoxin Efficacy in the Clinical Application
1998 · Hisataka Shoji, Tohru Tani, et al. · Therapeutic Apheresis and Dialysis · 149
Modulation of Plasma Metalloproteinase-9 Concentrations and Peripheral Blood Monocyte mRNA Levels in Patients with Septic Shock: Effect of Fiber-Immobilized Polymyxin B Treatment
1998 · Tsukasa Nakamura, Isao Ebihara, et al. · The American Journal of the Medical Sciences · 84
Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: Decrease in plasma levels of soluble P-selectin, platelet factor 4 and β-thromboglobulin
1999 · T. Nakamura, I. Ebihara, et al. · Inflammation Research · 77
Effect of Polymyxin B-Immobilized Fiber on Blood Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Levels in Acute Respiratory Distress Syndrome Patients
2004 · Tsukasa Nakamura, Yasuhiro Kawagoe, et al. · Blood Purification · 70
Novel Insights into the Direct Removal of Endotoxin by Polymyxin B Hemoperfusion
2017 · Alexander D. Romaschin, Christina V. Obiezu-Forster, et al. · Blood Purification · 63
Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock
2009 · Tsukasa Nakamura, Eiichi Sato, et al. · Pharmacological Research · 47
Endotoxin Adsorption by Polymyxin B Immobilized Fiber Column in Patients with Systemic Inflammatory Response Syndrome: The Japanese Experience
2003 · Takashi Sato, Hisataka Shoji, et al. · Therapeutic Apheresis and Dialysis · 45
Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock
2021 · Hisataka Shoji, Steven M. Opal · International Journal of Molecular Sciences · 38
PDF
Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin- resistant Staphylococcus aureus
2003 · T. Nakamura, C. Ushiyama, et al. · Journal of Hospital Infection · 38
Extracorporeal Removal of Endotoxin: The Polymyxin B-Immobilized Fiber Cartridge
2010 · Tohru Tani, Hisataka Shoji, et al. · Contributions to nephrology · 36
Hemoperfusion with Polymyxin B Immobilized Fibers for Urinary Albumin Excretion in Septic Patients with Trauma
2002 · Tsukasa Nakamura, Chifuyu Ushiyama, et al. · ASAIO Journal · 27
Effect of hemoperfusion with polymyxin B-immobilized fiber on plasma endothelin-1 and endothelin-1 mRNA in monocytes from patients with sepsis
1998 · I Ebihara, T Nakamura, et al. · American Journal of Kidney Diseases · 26
Anti-endotoxin Properties of Polymyxin B-immobilized Fibers
2019 · Tohru Tani, Tomoharu Shimizu, et al. · Advances in experimental medicine and biology · 25
PDF
Hemoperfusion with Polymyxin B-Immobilized Fiber in Septic Patients with Methicillin-Resistant Staphylococcus aureus-Associated Glomerulonephritis
2003 · Tsukasa Nakamura, Chifuyu Ushiyama, et al. · Nephron Clinical Practice · 25
Hemoperfusion with Polymyxin B- Immobilized Fiber Attenuates the Increased Plasma Levels of Thrombomodulin and von Willebrand Factor from Patients with Septic Shock
1998 · Tsukasa Nakamura, Yukiko Suzuki, et al. · Blood Purification · 25
Changes in Plasma Interleukin-18 by Direct Hemoperfusion with Polymyxin B-Immobilized Fiber in Patients with Septic Shock
2005 · Tsukasa Nakamura, Yasuhiro Kawagoe, et al. · Blood Purification · 22
Potential survival benefit and early recovery from organ dysfunction with polymyxin B hemoperfusion: perspectives from a real-world big data analysis and the supporting mechanisms of action
2022 · Hisataka Shoji, Ricard Ferrer · Journal of Anesthesia Analgesia and Critical Care · 20
PDF
Effect Over Time of Endotoxin Adsorption Therapy in Sepsis
2005 · Takuya Ueno, Michio Sugino, et al. · Therapeutic Apheresis and Dialysis · 19
Effects of hemoperfusion with polymyxin B-immobilized fibre on serum neopterin and soluble interleukin-2 receptor concentrations in patients with septic shock
1998 · T. Nakamura, I. Ebihara, et al. · Journal of Infection · 18
Effects of Hemoperfusion on Serum Cardiac Troponin T Concentrations Using Polymyxin B-Immobilized Fibers in Septic Patients Undergoing Hemodialysis
2002 · Tsukasa Nakamura, Chifuyu Ushiyama, et al. · ASAIO Journal · 17
Removal of Endotoxin in Blood by Polymyxin B Immobilized Polystyrene‐Derivative Fiber
2002 · Kazuo Teramoto, Yoshiaki Nakamoto, et al. · Therapeutic Apheresis and Dialysis · 14
Early introduction of hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
2005 · H Kushi, H Shoji, et al. · Critical Care · 12
PDF
Polymyxin B–Immobilized Fiber Hemoperfusion With the PMX-05R Column in Elderly Patients Suffering From Septic Shock
2007 · Tsukasa Nakamura, Yasuhiro Kawagoe, et al. · The American Journal of the Medical Sciences · 9
Effect of polymyxin B-immobilized fibre on various mediators in patients with hypothermic sepsis
2001 · T. Nakamura, C. Ushiyama, et al. · Clinical Intensive Care · 8
Works count: 60
Citation count: 1,350
H-index: 19
I10-index: 23
Year
Topic
Type